1. Home
  2. STKH vs RDHL Comparison

STKH vs RDHL Comparison

Compare STKH & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Steakholder Foods Ltd.

STKH

Steakholder Foods Ltd.

HOLD

Current Price

$2.62

Market Cap

3.6M

ML Signal

HOLD

Logo Redhill Biopharma Ltd.

RDHL

Redhill Biopharma Ltd.

HOLD

Current Price

$1.19

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STKH
RDHL
Founded
2018
2009
Country
Israel
Israel
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
3.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
STKH
RDHL
Price
$2.62
$1.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
122.4K
68.3K
Earning Date
04-02-2026
09-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,000.00
$9,550,000.00
Revenue This Year
N/A
$381.91
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
157.62
52 Week Low
$2.13
$1.01
52 Week High
$72.80
$7.00

Technical Indicators

Market Signals
Indicator
STKH
RDHL
Relative Strength Index (RSI) 40.78 44.82
Support Level $2.44 $1.10
Resistance Level $2.70 $1.23
Average True Range (ATR) 0.32 0.05
MACD -0.03 0.01
Stochastic Oscillator 4.24 31.25

Price Performance

Historical Comparison
STKH
RDHL

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

Share on Social Networks: